The CardioMetabolic Health Alliance: Working Toward a New Care Model for the Metabolic Syndrome

J Am Coll Cardiol. 2015 Sep 1;66(9):1050-67. doi: 10.1016/j.jacc.2015.06.1328.

Abstract

The Cardiometabolic Think Tank was convened on June 20, 2014, in Washington, DC, as a "call to action" activity focused on defining new patient care models and approaches to address contemporary issues of cardiometabolic risk and disease. Individual experts representing >20 professional organizations participated in this roundtable discussion. The Think Tank consensus was that the metabolic syndrome (MetS) is a complex pathophysiological state comprised of a cluster of clinically measured and typically unmeasured risk factors, is progressive in its course, and is associated with serious and extensive comorbidity, but tends to be clinically under-recognized. The ideal patient care model for MetS must accurately identify those at risk before MetS develops and must recognize subtypes and stages of MetS to more effectively direct prevention and therapies. This new MetS care model introduces both affirmed and emerging concepts that will require consensus development, validation, and optimization in the future.

Keywords: cardiometabolic; cardiovascular disease; insulin resistance; obesity.

Publication types

  • Review

MeSH terms

  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / epidemiology*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / therapy
  • District of Columbia
  • Evidence-Based Medicine
  • Health Promotion / organization & administration*
  • Humans
  • Hypertension / diagnosis
  • Hypertension / epidemiology
  • Hypertension / therapy
  • Metabolic Syndrome / diagnosis
  • Metabolic Syndrome / epidemiology*
  • Metabolic Syndrome / therapy*
  • Models, Cardiovascular
  • Obesity / diagnosis
  • Obesity / epidemiology
  • Obesity / therapy
  • Societies, Medical
  • Survival Analysis
  • Treatment Outcome